409 related articles for article (PubMed ID: 35886945)
1. Toxicologic Concerns with Current Medical Nanoparticles.
Cheng TM; Chu HY; Huang HM; Li ZL; Chen CY; Shih YJ; Whang-Peng J; Cheng RH; Mo JK; Lin HY; Wang K
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886945
[TBL] [Abstract][Full Text] [Related]
2. Nanotoxicology: advances and pitfalls in research methodology.
Azhdarzadeh M; Saei AA; Sharifi S; Hajipour MJ; Alkilany AM; Sharifzadeh M; Ramazani F; Laurent S; Mashaghi A; Mahmoudi M
Nanomedicine (Lond); 2015; 10(18):2931-52. PubMed ID: 26370561
[TBL] [Abstract][Full Text] [Related]
3. Review of the effects of manufactured nanoparticles on mammalian target organs.
Wu T; Tang M
J Appl Toxicol; 2018 Jan; 38(1):25-40. PubMed ID: 28799656
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity of Nanomaterials: Using Nanotoxicology to Address the Safety Concerns of Nanoparticles.
Saifi MA; Khan W; Godugu C
Pharm Nanotechnol; 2018; 6(1):3-16. PubMed ID: 29065848
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the toxicity of selected types of nanochemicals.
Kumar V; Kumari A; Guleria P; Yadav SK
Rev Environ Contam Toxicol; 2012; 215():39-121. PubMed ID: 22057930
[TBL] [Abstract][Full Text] [Related]
6. In-vitro in-vivo correlation (IVIVC) in nanomedicine: Is protein corona the missing link?
Jain P; Pawar RS; Pandey RS; Madan J; Pawar S; Lakshmi PK; Sudheesh MS
Biotechnol Adv; 2017 Nov; 35(7):889-904. PubMed ID: 28844973
[TBL] [Abstract][Full Text] [Related]
7. Towards an alternative testing strategy for nanomaterials used in nanomedicine: lessons from NanoTEST.
Dusinska M; Boland S; Saunders M; Juillerat-Jeanneret L; Tran L; Pojana G; Marcomini A; Volkovova K; Tulinska J; Knudsen LE; Gombau L; Whelan M; Collins AR; Marano F; Housiadas C; Bilanicova D; Halamoda Kenzaoui B; Correia Carreira S; Magdolenova Z; Fjellsbø LM; Huk A; Handy R; Walker L; Barancokova M; Bartonova A; Burello E; Castell J; Cowie H; Drlickova M; Guadagnini R; Harris G; Harju M; Heimstad ES; Hurbankova M; Kazimirova A; Kovacikova Z; Kuricova M; Liskova A; Milcamps A; Neubauerova E; Palosaari T; Papazafiri P; Pilou M; Poulsen MS; Ross B; Runden-Pran E; Sebekova K; Staruchova M; Vallotto D; Worth A
Nanotoxicology; 2015 May; 9 Suppl 1():118-32. PubMed ID: 25923349
[TBL] [Abstract][Full Text] [Related]
8. Organization of research team for nano-associated safety assessment in effort to study nanotoxicology of zinc oxide and silica nanoparticles.
Kim YR; Park SH; Lee JK; Jeong J; Kim JH; Meang EH; Yoon TH; Lim ST; Oh JM; An SS; Kim MK
Int J Nanomedicine; 2014; 9 Suppl 2(Suppl 2):3-10. PubMed ID: 25565821
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial precious-metal nanoparticles and their use in novel materials.
Senior K; Müller S; Schacht VJ; Bunge M
Recent Pat Food Nutr Agric; 2012 Dec; 4(3):200-9. PubMed ID: 23013409
[TBL] [Abstract][Full Text] [Related]
10. Where Is Nano Today and Where Is It Headed? A Review of Nanomedicine and the Dilemma of Nanotoxicology.
Domingues C; Santos A; Alvarez-Lorenzo C; Concheiro A; Jarak I; Veiga F; Barbosa I; Dourado M; Figueiras A
ACS Nano; 2022 Jul; 16(7):9994-10041. PubMed ID: 35729778
[TBL] [Abstract][Full Text] [Related]
11. Biophysicochemical perspective of nanoparticle compatibility: a critically ignored parameter in nanomedicine.
Hassan S; Singh AV
J Nanosci Nanotechnol; 2014 Jan; 14(1):402-14. PubMed ID: 24730271
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic Insights into the Biological Effects of Engineered Nanomaterials: A Focus on Gold Nanoparticles.
Nguyen NHA; Falagan-Lotsch P
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835521
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in green nanoparticulate systems for drug delivery: efficient delivery and safety concern.
Lam PL; Wong WY; Bian Z; Chui CH; Gambari R
Nanomedicine (Lond); 2017 Feb; 12(4):357-385. PubMed ID: 28078952
[TBL] [Abstract][Full Text] [Related]
14. Novel Methods and Approaches for Safety Evaluation of Nanoparticle Formulations: A Focus Towards
Tirumala MG; Anchi P; Raja S; Rachamalla M; Godugu C
Front Pharmacol; 2021; 12():612659. PubMed ID: 34566630
[TBL] [Abstract][Full Text] [Related]
15. Molecular Mechanisms, Characterization Methods, and Utilities of Nanoparticle Biotransformation in Nanosafety Assessments.
Cai X; Liu X; Jiang J; Gao M; Wang W; Zheng H; Xu S; Li R
Small; 2020 Sep; 16(36):e1907663. PubMed ID: 32406193
[TBL] [Abstract][Full Text] [Related]
16. Fabricated nanoparticles: current status and potential phytotoxic threats.
Yadav T; Mungray AA; Mungray AK
Rev Environ Contam Toxicol; 2014; 230():83-110. PubMed ID: 24609519
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticles, nanotechnology and pulmonary nanotoxicology.
Ferreira AJ; Cemlyn-Jones J; Robalo Cordeiro C
Rev Port Pneumol; 2013; 19(1):28-37. PubMed ID: 23265236
[TBL] [Abstract][Full Text] [Related]
18. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology.
Oberdörster G
J Intern Med; 2010 Jan; 267(1):89-105. PubMed ID: 20059646
[TBL] [Abstract][Full Text] [Related]
19. Nanomaterials in biology and medicine: a new perspective on its toxicity and applications.
Saravanan J; Nair A; Krishna SS; Viswanad V
Drug Chem Toxicol; 2024 Apr; ():1-18. PubMed ID: 38682270
[TBL] [Abstract][Full Text] [Related]
20. What function of nanoparticles is the primary factor for their hyper-toxicity?
Ali M
Adv Colloid Interface Sci; 2023 Apr; 314():102881. PubMed ID: 36934512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
